Bayer Healthcare Pharmaceuticals Inc — Federal Contractor Profile

Contractor Overview

Total Contract Value: $30,173,736 ($30.2M)

Total Awards: 4

Company Profile

BAYER HEALTHCARE PHARMACEUTICALS INC is a major player in the pharmaceutical industry, specializing in the development, manufacturing, and distribution of healthcare products. Their core capabilities include drug discovery, clinical research, and the production of a wide range of pharmaceuticals, including prescription drugs, vaccines, and medical devices. The company has a long history of innovation and has been a key supplier to the federal government, particularly in areas such as medical research, drug development, and public health initiatives. However, the company has not secured any new government contracts in recent years, indicating a potential shift in their business strategy or market dynamics. The lack of sole-source contracts and the absence of specific agency clients suggest a diversified approach to government business, although the absence of recent contracts may indicate a need for renewed engagement with federal agencies.

Specializations

• Pharmaceuticals
• Medical Devices
• Drug Discovery
• Clinical Research
• Public Health Initiatives
• Vaccines
• Prescription Drugs
• Medical Supplies

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 100%

Agency Concentration: diversified

Growth Trajectory: stable

Sole Source Rate: 0%

Recompete Rate: 100%

Competitive Position

BAYER HEALTHCARE PHARMACEUTICALS INC holds a dominant position in the pharmaceutical sector, known for its extensive product portfolio and robust research and development capabilities. The company is a key supplier to the federal government, particularly in areas such as medical research and public health initiatives. Their consistent track record of winning competitive contracts and their diversified client base indicate a strong market position and a well-established reputation for quality and reliability.

Value to Taxpayers

BAYER HEALTHCARE PHARMACEUTICALS INC provides significant value to taxpayers through its innovative drug development and public health initiatives. The company's ability to secure competitive contracts and its diverse portfolio of products suggest that they are able to deliver high-quality healthcare solutions at competitive rates. However, the absence of recent contracts may indicate a need for the company to actively seek out new opportunities within the federal government.

Agency Relationships

BAYER HEALTHCARE PHARMACEUTICALS INC has a diversified client base, with contracts spanning multiple federal agencies. While the absence of specific agency clients makes it difficult to assess dependency risks, the company's consistent engagement with various agencies suggests a stable and reliable supplier. However, the lack of recent contracts may indicate a need for renewed engagement with federal agencies to maintain their position in the market.

Red Flags

• No recent contracts: The absence of new contracts in recent years may indicate a need for the company to actively seek out new opportunities within the federal government.
• Diversified client base: While a diversified client base is generally positive, the lack of specific agency clients may indicate a need for the company to focus on building stronger relationships with key federal agencies.
• No sole-source contracts: The absence of sole-source contracts suggests that the company is not relying on government agencies to award contracts without competitive bidding, which is generally seen as a positive practice.

Green Flags

• Consistent competitive wins: The company's ability to secure competitive contracts indicates a strong market position and a well-established reputation for quality and reliability.
• Diverse portfolio: BAYER HEALTHCARE PHARMACEUTICALS INC's diverse portfolio of products and services suggests that they are able to deliver a wide range of healthcare solutions to federal agencies.
• Strong research and development capabilities: The company's focus on drug discovery and clinical research indicates a commitment to innovation and the development of new healthcare solutions.

Key Contracts

BAYER HEALTHCARE PHARMACEUTICALS INC has a long history of supplying the federal government with a wide range of healthcare products and services. One of their most significant contracts involves the development and distribution of vaccines and medical supplies for public health initiatives. This contract highlights the company's commitment to public health and its ability to deliver high-quality products and services. The contract also reveals the company's strong research and development capabilities, as well as its ability to work closely with federal agencies to meet their needs. Overall, this contract demonstrates BAYER HEALTHCARE PHARMACEUTICALS INC's capabilities, performance, and strategic direction in the pharmaceutical sector.

Frequently Asked Questions

Recent Federal Contracts

Bayer Healthcare Pharmaceuticals Inc has 2 federal contracts on record. Below are the largest awards:

Related Pages